Cargando…

Biochemical indicators for neuronal regeneration during intrathecal triamcinolone application in multiple sclerosis

Detalles Bibliográficos
Autores principales:	Müller, Thomas, Lütge, Sven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396096/ https://www.ncbi.nlm.nih.gov/pubmed/25878582 http://dx.doi.org/10.4103/1673-5374.153682

Ejemplares similares

Efficacy of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients with spinal symptoms
por: Hellwig, Kerstin, et al.
Publicado: (2004)

Systemic Effects by Intrathecal Administration of Triamcinolone Acetonide in Patients With Multiple Sclerosis
por: Hoeflich, Andreas, et al.
Publicado: (2020)

Repeat Intrathecal Triamcinolone Acetonide Application Reduces Acute Occurring Painful Dysesthesia in Patients with Relapsing Remitting Multiple Sclerosis
por: Hellwig, Kerstin, et al.
Publicado: (2006)

Repeated Intrathecal Triamcinolone Acetonide Administration in Progressive Multiple Sclerosis: A Review
por: Abu-Mugheisib, Mazen, et al.
Publicado: (2011)

Effects of Repeated Intrathecal Triamcinolone-Acetonide Application on Cerebrospinal Fluid Biomarkers of Axonal Damage and Glial Activity in Multiple Sclerosis Patients
por: Rommer, P. S., et al.
Publicado: (2014)

Intrathecal Inflammation in Progressive Multiple Sclerosis
por: Monaco, Salvatore, et al.
Publicado: (2020)

Neuronal and endothelial transglutaminase-2 expression in experimental autoimmune encephalomyelitis and multiple sclerosis
por: Pearse, Damien D., et al.
Publicado: (2021)

Neuronal gene transcription modulates demyelination and remyelination in a mouse model of multiple sclerosis
por: Anastasiadou, Sofia, et al.
Publicado: (2015)

N-Propionylmannosamine: using biochemical glycoengineering to promote peripheral nerve regeneration
por: Koulaxouzidis, Georgios, et al.
Publicado: (2015)

Intrathecal corticosteroids might slow Alzheimer’s disease progression
por: Alisky, Joseph Martin
Publicado: (2008)

Serotonin controls axon and neuronal regeneration in the nervous system: lessons from regenerating animal models
por: Sobrido-Cameán, Daniel, et al.
Publicado: (2018)

Multi-omics insights into neuronal regeneration and re-innervation
por: Chauhan, Muhammad Zain, et al.
Publicado: (2020)

Intrathecal T‐cell clonal expansions in patients with multiple sclerosis
por: de Paula Alves Sousa, Alessandra, et al.
Publicado: (2016)

Association of the retinal vasculature, intrathecal immunity, and disability in multiple sclerosis
por: Noll, Christina, et al.
Publicado: (2022)

Intrathecal, Not Systemic Inflammation Is Correlated With Multiple Sclerosis Severity, Especially in Progressive Multiple Sclerosis
por: Milstein, Joshua L., et al.
Publicado: (2019)

Drug repurposing for neuroregeneration in multiple sclerosis
por: Küry, Patrick, et al.
Publicado: (2018)

Targeting metabolism to treat multiple sclerosis
por: Bhargava, Pavan
Publicado: (2020)

Multiple sclerosis drug repurposing for neuroregeneration
por: Göttle, Peter, et al.
Publicado: (2023)

Galectin-3 prospects as a therapeutic agent for multiple sclerosis
por: Thomas, Laura, et al.
Publicado: (2019)

From neurogenesis to neuronal regeneration: the amphibian olfactory system as a model to visualize neuronal development in vivo
por: Manzini, Ivan
Publicado: (2015)

Enhanced neuronal degradation of amyloid-β oligomers allows synapse regeneration
por: Bate, Clive
Publicado: (2015)

Is ATP a key player in conditioning neurons to support axonal regeneration?
por: Bo, Xuenong
Publicado: (2018)

Intracellular compartmentation of cAMP promotes neuroprotection and regeneration of CNS neurons
por: Cameron, Evan G., et al.
Publicado: (2017)

The history of the use of intrathecal prostigmine to achieve fertility in men with spinal cord injuries
por: Silver, J. R., et al.
Publicado: (2019)

Role of CD20(+) T cells in multiple sclerosis: implications for treatment with ocrelizumab
por: Gingele, Stefan, et al.
Publicado: (2019)

Multiple Sclerosis: Overview of Disease-Modifying Agents
por: Finkelsztejn, Alessandro
Publicado: (2014)

Perspectives on neuroreparative therapies for treating multiple sclerosis
por: Xiao, Junhua
Publicado: (2015)

Tremor in Multiple Sclerosis—An Overview and Future Perspectives
por: Makhoul, Karim, et al.
Publicado: (2020)

Immunological role of sulfatide in the pathogenesis of multiple sclerosis
por: Hamatani, Mio, et al.
Publicado: (2023)

Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis
por: Lin, Yen Chih, et al.
Publicado: (2015)

Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis
por: Komori, Mika, et al.
Publicado: (2016)

Predictors for Therapy Response to Intrathecal Corticosteroid Therapy in Multiple Sclerosis
por: Vohl, Katja, et al.
Publicado: (2019)

Intrathecal kappa free light chains as markers for multiple sclerosis
por: Vecchio, D., et al.
Publicado: (2020)

Effects of intrathecal Baclofen in reducing tremors in patients with multiple sclerosis
por: Aldarwish, Walaa A., et al.
Publicado: (2023)

Semaphorin 3A: from growth cone repellent to promoter of neuronal regeneration
por: Tang, Bor Luen
Publicado: (2018)

Neural correlates of the Heidelberg Music Therapy: indicators for the regeneration of auditory cortex in tinnitus patients?
por: Krick, Christoph M., et al.
Publicado: (2015)

Ependymal cells and multiple sclerosis: proposing a relationship
por: Hatrock, Dale, et al.
Publicado: (2019)

Orexin/hypocretinin in multiple sclerosis and experimental autoimmune encephalomyelitis
por: Pallais, Jean Pierre, et al.
Publicado: (2019)

Neuronal cell death and regeneration in diseases associated with advanced glycation end-products accumulation
por: Bikbova, Guzel, et al.
Publicado: (2014)

Adenosine A(2A) receptors in neuronal outgrowth: a target for nerve regeneration?
por: Ribeiro, Filipa F., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7t7sjuvgmom24r6dnqncatqsrj